RxDoctor Payments DataLook up a doctor →

Veronica McGregor, MD

Endocrinology, Diabetes & Metabolism · Saint Louis, MONPI 1154395614

Payments from drug & device makers

$6,757in general payments, 2019–2025

Across 444 payments — averaging $15.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Dexcom, Inc.$725
  • Novo Nordisk$619
  • Medtronic$473
  • Lilly USA, LLC$345
  • Sequel Med Tech, LLC$302
  • plus $3K from 37 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott138$1,271
Dexcom, Inc.54$725
Novo Nordisk34$619
Medtronic(2 entities)20$473
Lilly USA, LLC16$345
Sequel Med Tech, LLC20$302
Amgen16$280
Novartis13$247
Sanofi-aventis U.S. LLC12$230
Xeris Pharmaceuticals, Inc.11$225
AbbVie9$189
Bayer9$168
Recordati_rare_diseases_inc.6$148
AstraZeneca(2 entities)9$146
Radius Health, Inc.6$132
Amarin Pharma, Inc.8$127
Mannkind Corporation6$121
Boehringer Ingelheim6$113
Almatica Pharma LLC5$90
Lifescan, Inc.4$72
Corcept Therapeutics3$65
BETA Bionics, Inc.6$57
IBSA Pharma Inc.3$55
Antares Pharma, Inc.3$53
Madrigal Pharmaceuticals1$46
Merck3$45
Amneal Pharmaceuticals LLC2$38
Amryt Pharma Holdings Ltd2$37
Regeneron Healthcare Solutions, Inc.2$36
Amphastar Pharmaceuticals, Inc.2$36
Nevro Corp.1$31
Kowa Pharmaceuticals America, Inc.2$25
Ascendis Pharma Endocrinology Inc1$25
Esperion Therapeutics, Inc.1$23
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$22
Verity Pharmaceuticals Inc.1$22
Neurocrine Biosciences, Inc.1$21
Acella Pharmaceuticals, LLC1$19
Averitas Pharma Inc.1$18
Tandem Diabetes Care, Inc.2$18
Insulet Corporation1$15
Johnson & Johnson1$13
Clarus Therapeutics Inc.1$13

How this compares

$6,757 in reported general payments places this provider in the 70th percentile of 182 endocrinology, diabetes & metabolism providers in Missouri.

See all endocrinology, diabetes & metabolism providers in Missouri →

Medicare billing

Part B allowed, 2024
$80,080
Medicare patients
339
Services billed
964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →